2-[3-Cyano-4-(4-tert-butylbenzyloxy)]phenylpyrimidine-4-ol

ID: ALA4857117

PubChem CID: 164610317

Max Phase: Preclinical

Molecular Formula: C22H21N3O2

Molecular Weight: 359.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1ccc(COc2ccc(-c3nccc(O)n3)cc2C#N)cc1

Standard InChI:  InChI=1S/C22H21N3O2/c1-22(2,3)18-7-4-15(5-8-18)14-27-19-9-6-16(12-17(19)13-23)21-24-11-10-20(26)25-21/h4-12H,14H2,1-3H3,(H,24,25,26)

Standard InChI Key:  QMBFRCJBEHLILL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   17.9974  -22.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9963  -22.9910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7043  -23.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4140  -22.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4112  -22.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7025  -21.7626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1143  -21.7579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8238  -22.1655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5295  -21.7549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5269  -20.9369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8127  -20.5311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1099  -20.9440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2883  -23.3990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7071  -24.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7069  -25.0348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8067  -19.7139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5809  -22.9899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8728  -23.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1662  -22.9865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4587  -23.3939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4576  -24.2120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1699  -24.6210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8746  -24.2113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7501  -24.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0422  -24.2127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7505  -25.4381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0379  -25.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  5  7  1  0
  2 13  1  0
 14 15  3  0
  3 14  1  0
 11 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4857117

    ---

Associated Targets(non-human)

XDH Xanthine dehydrogenase (2296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 4.60#Rotatable Bonds: 4
Polar Surface Area: 79.03Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.55CX Basic pKa: 0.94CX LogP: 5.72CX LogD: 5.72
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -1.36

References

1. Sun M, Zhao J, Mao Q, Yan C, Zhang B, Yang Y, Dai X, Gao J, Lin F, Duan Y, Zhang T, Wang S..  (2021)  Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.,  38  [PMID:33838610] [10.1016/j.bmc.2021.116117]

Source